LONDON --�Micro-chip designer�ARM Holdings� (LSE: ARM ) (NASDAQ: ARMH ) has long been a stock market darling. The huge rating that it traded on 10 years ago has been fully justified by its recent profitability.
Will buyers today be rewarded in the long term?
ARM has probably been the U.K.'s biggest beneficiary of the smartphone boom. In the last five years, its shares are up almost ninefold. In that time, dividends per share have more than doubled.
Its booming profits will be sure to attract competitors to its market. My concern is that, in the long term, shareholder returns could suffer as a consequence.
ARM currently trades on a 2013 price-to-earnings (P/E) ratio of 46.3 times expectations. The shares would fall hard from here if growth were to slow at any point in the next few years.
Hargreaves Lansdown
Investment shop-window�Hargreaves Lansdown� (LSE: HL ) dominates the U.K. market. The company continues to exploit its first-mover advantage, yielding impressive returns for shareholders.
Hot Mid Cap Stocks To Own For 2015: Arena Pharmaceuticals Inc.(ARNA)
Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company?s clinical development programs include lorcaserin that has completed two pivotal Phase III clinical trials for the treatment of weight management, including weight loss and maintenance of weight loss; and APD811, which is under Phase I clinical trial for the treatment of pulmonary arterial hypertension. Its preclinical development programs include APD334, for the treatment of autoimmune diseases, including multiple sclerosis and rheumatoid arthritis. The company also researches and develops cannabinoid, receptor agonists for the treatment of osteoarthritis and pain; and GPR119 agonists for the treatment of type 2 diabetes. Its other development programs, which had completed Phase I clinical trial include APD597 for th e treatment of type II diabetes; APD916 for the treatment of narcolepsy and cataplexy; and APD791 for the treatment of arterial thrombosis. In addition, the company provides manufacturing services. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.
Advisors' Opinion:- [By Sean Williams]
If that's the case, then it could mean big business for the duo of Arena Pharmaceuticals (NASDAQ: ARNA ) and VIVUS (NASDAQ: VVUS ) , which both have chronic weight-management drugs approved by the Food and Drug Administration. Arena's Belviq was approved in June last year but only made it to pharmacy shelves within the past week, as it had been awaiting scheduling from the Drug Enforcement Agency. VIVUS' Qsymia, on the other hand, has been available to the public since November, although sales have been tempered because few insurance companies are covering the drug thus far. It should be interesting to see which drug comes out on top, as Belviq had a better safety profile in clinical trials, but Qsymia offered the better overall weight-loss results in trials in percentage terms. Perhaps the pie is big enough for both companies to succeed?�
- [By Maxx Chatsko]
Obesity is a growing pandemic for many industrialized nations, especially in the U.S., where it now affects almost 36% of adults and 17% of adolescents. As with any sweeping problem, there are many ways to attack obesity. One new approach is through weight-loss pills that have successfully completed the regulatory gauntlet of clinical trials and scientific panels. In the last year alone, the Food and Drug Administration approved Belviq from Arena Pharmaceuticals (NASDAQ: ARNA ) and Qsymia from VIVUS (NASDAQ: VVUS ) . Both drugs work by suppressing the appetite and have demonstrated their effectiveness and safety in clinical trials.
Top Long Term Stocks To Watch For 2014: Techne Corporation(TECH)
TECHNE Corporation develops, manufactures, and sells biotechnology products, and hematology calibrators and controls worldwide. The company?s Biotechnology segment offers proteins, such as cytokines, and enzyme substrates and inhibitors; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits for the detection of human and animal proteins, and immunoassays that allow researchers to quantify a specific analyte in a biological fluids sample; clinical diagnostic immunoassay kits consisting of erythropoietin, transferrin receptor, and beta2-microglobulin immunoassays for use as in vitro diagnostic devices; flow cytometry products, such as fluorochrome labeled antibodies and kits; intracellular cell signaling products, including antibodies, phospho-specific antibodies, antibody arrays, active caspases, kinases, and phosphatases, and ELISA assays to measure the activity of apoptotic and signaling molecules; and natural and synthetic c hemical compounds for use as agonists, antagonists, and inhibitors of various biological functions by investigators. Its Hematology segment provides whole blood CBC controls controls and calibrators; linearity and reportable range controls for the assessment of the linearity of hematology analyzers for white blood cells, red blood cells, platelets, and reticulocytes; whole blood reticulocyte controls for manual and automated counting of reticulocytes; whole blood flow cytometry controls for the identification and quantification white blood cells; whole blood glucose/hemoglobin control to monitor instruments, which measure glucose and hemoglobin in blood; erythrocyte sedimentation rate control to monitor erythrocyte sedimentation rate tests; and multi-purpose platelet reference controls, such as Platelet-Trol II and Platelet-Trol Extended for use by automated and semi-automated analyzers, which monitor platelet levels. The company was founded in 1976 and is headquartered in M inneapolis, Minnesota.
Advisors' Opinion:- [By Rich Duprey]
Biologics researcher�Techne� (NASDAQ: TECH ) �will pay a regular quarterly dividend of $0.30 on May 24 to the holders of record at the close of business on May 10.
- [By Rich Duprey]
Medical device maker Techne (NASDAQ: TECH ) announced today that it's taking a 100% ownership stake in�Bionostics Holdings for $104 million cash.
Top Long Term Stocks To Watch For 2014: Century Peak Metals Holdings Corp (CPM)
Century Peak Metals Holdings Corporation is engaged in promoting, operating, managing, holding, acquiring or investing in corporations or entities that are engaged in mining activities or mining-related activities. It also invests in real estate development and energy. Its subsidiaries include Century Peak Corporation (CPC), Century Hua Guang Smelting Incorporated (CHGSI), Century Sidewide Smelting Inc. (CSSI) and Century Summit Carrier, Inc. (CSCI). The principal activities of CPC is to invest in and engage in the business of operating and mining of mineral resources in the Philippines, such as iron ore, copper, gold, silver, lead, manganese, chromites, nickel etc. and prospecting, exploring, milling, concentrating, converting, smelting, treating, refining and manufacturing, and preparing for the market. Advisors' Opinion:- [By kcpl]
Corning is focusing on its growth strategies. Management had already discussed in the previous quarter that it plans to quickly integrate Corning Precision Materials (CPM) in Korea in order to realize synergies, gain further cost advantages, and increase its flexibility of glass supply. The company completed its acquisition of CPM in the first quarter. As a result of this acquisition, its display sales improved 55% to $1 billion.
Top Long Term Stocks To Watch For 2014: PrivateBancorp Inc.(PVTB)
PrivateBancorp, Inc. operates as the holding company for The PrivateBank and Trust Company that provides business and personal financial services to middle-market companies and business owners, executives, entrepreneurs, and families in the United States. The company?s deposit products include checking, savings, and money market accounts; interest and non-interest bearing demand deposits; and certificates of deposit. Its loan portfolio comprises commercial loans, including lines of credit to businesses for working capital needs, term loans, and letters of credit; commercial real estate loans; loans for the construction of single-family residential properties, multi-family properties, and commercial projects; mortgage loans; and residential, home equity, and personal loans. The company also provides private banking, investment management, trust, and investment agency services to high and ultra-high net-worth clients; custody, escrow, and tax-deferred exchange services; and investment management services to individuals, families, and foundations. In addition, it invests primarily in residential mortgage-backed securities and collateralized mortgage obligations. As of December 31, 2011, the company operated 18 branch locations in the Chicago market; and 10 branch locations in the Atlanta, Detroit, Kansas City, Milwaukee, and St. Louis metropolitan areas, as well as 29 automated teller machines located at its banking facilities. PrivateBancorp, Inc. was founded in 1989 and is headquartered in Chicago, Illinois.
Advisors' Opinion:- [By Laura Brodbeck]
Next week investors will be waiting for several key earnings reports including�General Electric Company (NYSE: GE), Intuitive Surgical, Inc. (NASDAQ: ISRG), Peabody Energy Corporation (NYSE: BTU), Nokia Corporation (NYSE: NOK), PrivateBancorp, Inc. (NASDAQ: PVTB),Yahoo! Inc. (NASDAQ: YHOO), Bank of America Corp (NYSE: BAC) and Verizon Communications Inc. (NYSE: VZ).
- [By Zacks]
Some better-ranked Midwest banks include First Interstate Bancsystem Inc. (NASDAQ: FIBK), Wintrust Financial Corporation (NASDAQ: WTFC) and PrivateBancorp, Inc. (NASDAQ: PVTB). All these stocks carry a Zacks Rank #1 (Strong Buy).
Top Long Term Stocks To Watch For 2014: Travelzoo Inc(TZOO)
Travelzoo Inc., an Internet media company, together with its subsidiaries, publishes travel and entertainment deals from travel and entertainment companies, and local businesses in North America and Europe. Its publications and products include the Travelzoo Websites, such as travelzoo.com, travelzoo.ca, travelzoo.co.uk, travelzoo.de, www.travelzoo.es, and travelzoo.fr; the Travelzoo Top 20 e-mail newsletter; and the Newsflash e-mail alert service. The company also operates SuperSearch, a pay-per-click travel search tool; Travelzoo Network, a network of third-party Websites that list deals published by Travelzoo; and Fly.com, a travel search engine that allows users to find the best prices on flights from various airlines and online travel agencies. In addition, it provides Local Deals and Getaways services that allow its subscribers to purchase vouchers for deals from local businesses, such as spas, hotels, and restaurants through the Travelzoo Website. As of December 31, 2011, the company?s advertiser base included approximately 2,000 travel companies, entertainment companies, and local businesses, including airlines, hotels, cruise lines, vacations packagers, tour operators, destinations, car rental companies, travel agents, theater and performing arts groups, restaurants, spas, and activity companies. Travelzoo Inc. was founded in 1998 and is headquartered in New York, New York.
Advisors' Opinion:- [By Tom Taulli]
Valuation: Even with after the Expedia stock sell-off, shares of EXPE remain far from cheap. EXPE stock is trading for a trailing P/E of 46 vs. 33 for Priceline and 23 for Travelzoo (TZOO).�And considering the recent volatility, investors are certainly jittery about EXPE stock. As a result, another earnings disappointment could have a severe impact.
- [By Rich Smith]
If you are a Travelzoo (NASDAQ: TZOO ) shareholder but own fewer than 25 shares, management would really appreciate it if you would just go away.
- [By Peter Graham]
The Q1 2014 Tripadvisor Inc (NASDAQ: TRIP) earnings report is due after the market closes on Tuesday, May 6th, with investors and traders alike who follow either the stock or large cap Priceline Group Inc (NASDAQ: PCLN), mid cap Expedia Inc (NASDAQ: EXPE) and small caps Travelzoo Inc (NASDAQ: TZOO) and Orbitz Worldwide, Inc (NYSE: OWW) should be paying attention to it. Aside from the Tripadvisor Inc earnings report, it should be said that Travelzoo Inc released 1Q 2014 earnings on April 17th and Expedia Inc released earnings last Thursday while the Q1 2014 Orbitz Worldwide earnings report is due today before the market opens and the Priceline Group Inc earnings report is due out on Thursday, May 8, at 9:30AM EDT. However, Tripadvisor Inc is a little different from these other travel booking companies as its main focus is to provide travel advice or reviews written by real travelers (which obviously leads to travel bookings that they make money on).
No comments:
Post a Comment